Can you provide information on spinal dural arteriovenous fistula (DAVF), including its presentation, diagnosis, and treatment options?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 16, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Spinal Dural Arteriovenous Fistula (SDAVF)

Overview

Spinal dural arteriovenous fistulas are the most common spinal vascular malformations (70-80% of all spinal AVMs), occurring predominantly in men in their 6th-7th decade of life, and require prompt diagnosis and treatment to prevent irreversible neurological damage 1, 2.

Clinical Presentation

Demographics

  • Male predominance: 75% of cases 1
  • Mean age: 63-65 years 1, 3
  • Diagnostic delay: Average 12-21 months from symptom onset to diagnosis 1, 3

Symptom Pattern

The presentation is insidious and progressive, commonly mistaken for degenerative spinal disease 4:

  • Gait disturbance (44% as first symptom) 1
  • Sensory disturbances (30% as first symptom) - notably, these do NOT improve with treatment 1
  • Motor weakness in lower extremities (present in all patients) 3
  • Bladder dysfunction (present in all patients) 3
  • Bowel dysfunction (83% of patients) 3
  • Back pain/radiculopathy (58% pre-treatment) 1

Anatomical Location

  • Lower thoracic region: 44.5% 1
  • Lumbar region: 28.4% 1
  • Thoracolumbar junction: Most common overall 5

Diagnosis

MRI Findings (Pathognomonic Features)

Look for these specific imaging characteristics on spinal MRI 4, 3:

  • Multisegmental T2 hyperintensity in the spinal cord
  • Prominent perimedullary flow voids (dilated veins on cord surface)
  • Contrast enhancement of the affected cord segments
  • Post-contrast images and MR angiography aid diagnosis 3

Critical pitfall: Despite these classic findings, all patients in one series were initially misdiagnosed both clinically and radiologically 3. Maintain high clinical suspicion in middle-aged/elderly patients with progressive myelopathy.

Definitive Diagnosis

Conventional spinal angiography (DSA) remains the gold standard for both diagnosis and treatment planning 6, 2. This provides:

  • High spatial and temporal resolution
  • Precise localization of the fistula point
  • Identification of feeding arterial vessels
  • Characterization of venous drainage patterns

Treatment

Treatment Selection Algorithm

Surgical ligation is the definitive first-line treatment for SDAVF 7, 8. The most recent and highest quality meta-analysis (2025) demonstrates:

  • Complete occlusion rates: Surgery 96.8% vs. Endovascular 72.5% (OR: 0.16, p<0.01) 8
  • Successful treatment rates: Surgery 97.5% vs. Endovascular 66.7% (OR: 0.11, p<0.01) 8
  • Initial treatment failure: Surgery 2.3% vs. Endovascular 32.2% (OR: 8.97, p<0.01) 8
  • Recurrence rates: Significantly lower with surgery (OR: 6.04, p<0.01) 8
  • Retreatment rates: Significantly lower with surgery (OR: 7.16, p<0.01) 8
  • Complication rates: Similar between both approaches 7, 8

Surgical Approach

The most common surgical techniques 1:

  • Single-level laminectomy (44.3%)
  • Single-level hemilaminectomy (40.0%)
  • Unilateral interlaminar fenestration (15.7%)

Preoperative coil embolization can be used in 6/10 cases to facilitate intraoperative localization of the fistula 4.

Endovascular Treatment

Reserved for cases where surgical access is difficult or patient factors preclude surgery 2. Uses liquid embolics, particles, or coils, but has substantially higher failure and recurrence rates 8.

Outcomes

Expected Improvements Post-Treatment

Motor function and gait show the most significant improvement, while sensory deficits typically do not improve 1:

  • Back pain/radiculopathy: Improves from 58% to 24.7% by discharge (p<0.001) 1
  • Motor scores (ASIA-MS): Median improvement from 94 to 100 (p=0.019) 1
  • Gait: Average 1.5-point improvement on mALS 3
  • Modified Aminoff-Logue scale: Median improvement from 5 to 2 at follow-up (p=0.006) 1
  • Sensory disturbances: No significant improvement (p=0.681) 1
  • Overall functional status: Average 1-point improvement on mRS 3

Treatment Complications

  • Overall complication rate: 19.8% 1
  • Incomplete/failed occlusion: 9.9% requiring retreatment 1
  • Radiation burns from spinal angiography 4
  • Pseudomeningocele at surgical site (typically resolves) 4

Critical Clinical Pearls

Early treatment is essential - neurological deficits are potentially reversible if treated promptly, but delayed treatment results in irreversible disability 5. The average 12-21 month diagnostic delay represents a critical window where permanent damage accumulates 1, 3.

Do not expect sensory improvement - counsel patients that while motor function, gait, pain, and bladder/bowel function typically improve, sensory deficits are likely permanent 1.

Obtain thoracolumbar MRI at minimum - the fistula level must be included in imaging, and most lesions occur in the thoracolumbar region 3.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.